Supernus Pharmaceuticals Inc (SUPN)
Net profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -1 | 60,711 | 53,424 | 126,950 | 113,056 |
| Revenue | US$ in thousands | 607,521 | 673,056 | 560,079 | 500,962 | 392,755 |
| Net profit margin | -0.00% | 9.02% | 9.54% | 25.34% | 28.79% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $-1K ÷ $607,521K
= -0.00%
The net profit margin of Supernus Pharmaceuticals Inc has experienced a declining trend over the past five years. The net profit margin decreased significantly from 28.79% in 2019 to 0.22% in 2023, indicating a substantial decline in profitability. This downward trend suggests that the company's ability to generate profits relative to its revenue has weakened over the period under consideration. Factors such as increased costs, pricing pressures, or changes in revenue mix may have contributed to the declining net profit margin. It is essential for Supernus Pharmaceuticals Inc to closely monitor its cost structure and revenue streams to improve its profitability and enhance shareholder value.
Peer comparison
Dec 31, 2023